Mayzent 0.25 mg, 1 mg, 2 mg film-coated tablets

*
Pharmacy Only: Prescription
  • Company:

    Novartis Ireland Limited
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Updated on 07 February 2024

File name

Mayzent REGPIL PF24-0004 clean Jan 2024.pdf

Reasons for updating

  • Improved presentation of PIL

Updated on 23 January 2024

File name

Mayzent REGSPC PF24-0011 Jan 2024_Clean.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 10 January 2024

File name

Mayzent REGPIL PF24-0004 clean Jan 2024.pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 10 January 2024

File name

MAYZENT REGSPC PF24-0004_Jan 24_Clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 August 2023

File name

Mayzent_REG PIL_PF23-0144_06.07.2023_clean_Nürnberg .pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 18 August 2023

File name

Mayzent_REG SPC_PF23-0144_06.07.2023_clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

EDM Updated on 22 February 2023

File name

12532_Mayzent_RMP_Patient-CaregiverReminderCard_SEPT22_LR2.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 22 February 2023

File name

12532_Mayzent_HCP_Checklist_SEPT22_LR4.pdf

Reasons for updating

  • Add New Doc

Free text change information supplied by the pharmaceutical company

HCP

Updated on 22 February 2023

File name

Mayzent FCT REGSPC PF 23-0016_Jan 2023 Clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 18 January 2023

File name

Mayzent REGPIL PF23-0016 Clean 12 Jan 2023.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions

Updated on 18 January 2023

File name

Mayzent FCT REGSPC PF 23-0016_Jan 2023 Clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 26 July 2022

File name

Mayzent all doses PIL R89 PF22-0135 clean 18.07.2022.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 26 July 2022

File name

Mayzent_REG SPC_PF22-0135_18.07.2022_clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 24 February 2022

File name

Mayzent REGPIL PF22-0047_Feb-22_Clean.pdf

Reasons for updating

  • Introduction of new pack/pack size

Updated on 24 February 2022

File name

Mayzent REGSPC PF22-0047_Feb-22_Clean.pdf

Reasons for updating

  • Other

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 January 2022

File name

MAYZENT_REGSPC PF 21-0319_Nov 2021_Clean.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 05 January 2022

File name

Mayzent REGPIL PF 21-0291 10.2021_Clean.pdf

Reasons for updating

  • New PIL for new product